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We systematically reviewed studies of the immune response to tuberculosis and the genetic
polymorphisms associated with Th1- or Th2-mediated cytokine expression in indigenous
populations. A bibliographic search was performed on the Medline and ISI databases and
included studies published between January 1980 and October 2011. The search terms were
tuberculosis, American Indians, Amerindian, indigenous, Indians, native people, aboriginal, immun*,
host immune, immune response, cytokine*, polymorphism*, and gene. Regardless of their design,
studies that evaluated immunoglobulin, cytokine levels and genetic polymorphisms that
altered cytokine expression were included. Thirteen studies met the inclusion criteria. The
majority of studies were performed in Latin America, and ﬁve investigated the Warao ethnic
group of Venezuela. Most of the investigations indirectly evaluated the immune response.
Higher anergy to the tuberculin skin test, higher IgG4 and IgM levels, higher IL-5 production
and lower TNF-, IL-12p40 and IFN- production were found in the indigenous populations.
The studies also reported a predominantly Th2-type response in these populations and a
possibly higher susceptibility to tuberculosis. A better understanding of the relevant geneticpolymorphisms and their role in immune regulation would help to clarify the immuno-
genetic mechanisms of TB infection in these populations. This information would be useful
for identifying new treatments and preventing infection and progression to active disease.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDntroductiont is estimated that 2 billion people are infected by Mycobac-
erium tuberculosis, but only 5–10% of infected people develop
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Este é um artigo Open Access sob a licençaactive disease.1 Immune responses to infection and dis-
ease depend on complex interactions between the etiologicale Federal da Grande Dourados, Rodovia Dourados, Itaúm, km 12,
Croda).
agent, the environment and the host. The reasons why some
people develop disease while others do not are yet to be
fully elucidated.2 The combined innate and adaptive immune
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responses play an important role in host defenses against
M. tuberculosis and can cause a broad spectrum of clinical
manifestations.3,4
The course of infection is regulated immunologically by
two distinct T lymphocyte populations that determine the
magnitude and nature of the immune response. The cellular
immune response is directly related to cytokine production
and is determined by the balance between the T helper 1
(Th1) and T helper 2 (Th2) responses. The Th1-type response
is linked to interleukin-12 (IL-12) and interferon-gamma
(IFN-) production, whereas the Th2-type response is linked
to the production of interleukin-4 (IL-4) and interleukin-5
(IL-5). Th2-type response, generally, induce a humoral (anti-
body) response critical in the defense against extracellular
pathogens. If the Th1-type response predominates after infec-
tion, the host will usually be protected against M. tuberculosis
and only develop a latent asymptomatic infection. If the Th2-
type response prevails, there may be progression to active
disease, with the more serious forms of the disease exhibiting
exuberant symptomatology and high bacterial loads.3,4 The
production of interleukin-10 (IL-10) plays an important role
in regulating the chronic or latent stages of the disease and
may lead to the endogenous reactivation of M. tuberculosis and
consequent host disease.5,6
Several polymorphisms have been described in genes asso-
ciated with cytokine expression. These polymorphisms can
induce a predominantly Th1 or Th2 immune response and
direct the course of infection.7,8
Even after considering possible errors in case reporting into
account, recent studies have suggested that the incidence of
tuberculosis (TB) is signiﬁcantly higher in indigenous than
non-indigenous populations of Latin America.9–11 Investiga-
tions conducted in Australia, Canada and the United States
have also suggested a higher incidence in native populations
than other ethnic groups.12–15 The shortage of resources to
manage TB in indigenous populations, associated to poverty,
a lack of access to health facilities for diagnosis and treatment,
a frequent alcohol use and unemployment may partly explain
the observed discrepancies.16,17 However, little is known about
the immune mechanisms associated with TB in indigenous
populations.
Recent studies conducted with different indigenous eth-
nic groups, have revealed that a large fraction of evaluated
individuals did not react to the tuberculin skin test (TST),
even in locations where the disease has a high prevalence
and BCG vaccine coverage exceeds 80% of the population.18–21
The objective of this investigation was to review studies of the
immune response to TB and the genetic polymorphisms asso-
ciated with the expression of cytokines involved in the Th1 or
Th2 immune responses in indigenous populations.
Methodology
We systematically reviewed primary scientiﬁc articles that
analyzed the cellular or humoral immune responses to TB
or the genetic polymorphisms associated with Th1- or Th2-
mediated cytokine expression in indigenous populations. A
bibliographical search was performed using the Medline and
ISI Web of Knowledge databases and was limited to studies13;17(3):363–368
published between January 1980 and October 2011. The search
strategy began broadly and was gradually reﬁned. It was based
on combinations of the following terms: tuberculosis, American
Indians, Amerindian, indigenous, Indians, native people, aboriginal,
immun*, host immune, immune response, cytokine*, polymorphism*,
and gene. A manual search was also used in reference lists for
the identiﬁed articles.
All studies in English, French, Spanish and Portuguese
that directly measured the immune response through
immunoglobulin or cytokine levels were included, regardless
of the design, as were studies of genetic polymorphisms that
affect cytokine expression.
Studies that only used indirect methods to evaluate immu-
nity to TB, such as the TST, were excluded. Studies were also
excluded if they reported changes in immune response caused
by other infectious diseases.
The ﬁltered data were independently organized by the
authors with the help of a standardized form. The names
of the authors, publication year and place, language, ethnic
group, sample size, participants’ ages, immune tests and rel-
evant genes were recorded.
Results and discussion
Thebibliographical search yielded 42 articles. Of these articles,
13 studies met the inclusion criteria. Seven studies investi-
gated the immune response to TB, and six analyzed genetic
polymorphisms associated with cytokine expression. Six of
the immunological studies were written in English, and one
was published in Spanish. All of the studies with a genetic
focus were published in English.
Over 10 ethnic groups were investigated, and most of these
groups were from Latin America. Five studies were conducted
on the indigenous people of the Warao ethnicity, who live in
the Amacuro Delta region in Venezuela. Native populations
of Brazil, Canada, Iran, Mexico, Norway and Taiwan were also
evaluated.
Most of the studies were based on small sample sizes. The
studies that assessed the largest population samples were
conducted on the Yanomami in 1997,18 the Xavante in 2010,22
and the Warao in 200823–27 (Table 1). Despite the small sample
sizes, both adults and children were included in our analysis.
OnlyGiampietro et al.27 evaluated theproliferative capacity
of peripheral blood mononuclear cells (PBMC) after treat-
ment with antigen and investigated the resulting cytokine
levels (Table 1). Most studies analyzed the humoral immune
response to TB18,23–27 by measuring the concentration of
immunoglobulins (IgG, IgG1, IgG2, IgG3, IgG4, IgM, IgA, saliva
IgA and IgE) and complement fractions (C3 and C4). A large
proportion of the studies used the TST as an indirect indica-
tor of the cellular immune response, and two also tested the
skin response to Candida as a control of the individual’s ability
to initiate a cellular response (Table 1).
Two studies analyzed immunoglobulin concentrations
with the objective of evaluating their sensitivity and speci-
ﬁcity for diagnostic use but not for measuring the strength of
the immune response.24,26
In a case–control study, cells were stimulated and
measured cytokines in 86 indigenous (Warao) and 34
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Table 1 – Characterization of the studies that examined the immune response to tuberculosis in indigenous populations.
Authors Year of publication Language Ethnic groups/location Design Sample size Immunoassay TST Age (y)
Sousa et al. 1997 English Yanomami/Brazil Observational 589 Immunoglobulin
levels
Yes Not speciﬁed
Sanchez-
Rodriguéz
et al.
2002 English Totonaca/Mexico Prospective
observational
55 IgG response to
Ag85
Yes 17–70
González et al. 2003 Spanish Warao/Venezuela Survey 107 Immunoglobulin
and complement
levels
Yes+ candida 0–15
Araujo et al. 2004 English Warao/Venezuela Survey 80 (34 indigenous
TB cases)
Immunoglobulin
levels
Yes+ candida 0–15
Araujo et al. 2006 English Warao/Venezuela Survey 209 Immunoglobulin
and complement
levels
Yes 15–60
Araujo et al. 2008 English Warao/Venezuela Prospective
Trial
295 (162 Warao) Immunoglobulin
levels
Yes 15–60
Giampietro
et al.
2010 English Warao/Venezuela Survey 86 (52 Warao) PBMC
stimulation and
cytokine levels
Yes 15–60
TST, tuberculin skin test.
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non-indigenous (Creole) people with the objective of identi-
fying differences in the immune responses of the two groups.
In this study, cells were treated with IL-12p40, IL-4, IL-5, IFN-
and TNF-. The indigenous group produced lower levels of IL-
12p40, TNF- and IFN- and a higher level of IL-5, indicating
that the Th2-type response predominated in this group. The
production of IL-12p40 is decisive for IFN- induction and con-
trol of the disease. All of the data indicate that the production
of IL-12p40 is reduced in the Warao and that the differences
in the immune responses of the two groups can partly explain
the elevated prevalence of TB in the Warao.27
Sousa et al. have evaluated the prevalence of TB and
TST responses among the Yanomami indigenous popu-
lation near the Brazil-Venezuela border. In addition, the
authors measured the concentrations of IgM and IgG anti-
bodies and their subclasses in 589 serum samples. These
data were compared to data collected from healthy mili-
tary personnel living in the same region. The TST responses
were lower in the indigenous population. The Yanomami
exhibited higher IgM and IgG4 (IL-4 dependent) production
and a negative correlation between TST response and IgM
production, suggesting the predominance of the Th2-type
response.18
Contrasting results were obtained by Araujo et al., who
had analyzed the TST responses and concentrations of the
immunoglobulins IgA (saliva), IgG,1–3 IgM and IgE in groups
of TB patients and non-patients from the Warao and the Cre-
ole populations of the Venezuelan Amacuro Delta region. The
authors did not observe differences in the IgG subclass con-
centrations between the groups.26
González et al. have performed cutaneous sensitivity tests
(TST and candida skin test) and measured the concentrations
of complement fractions C3 and C4 and the immunoglobu-
lins IgA, IgA saliva, IgE, IgG and IgM to analyze the immune
response of Warao children younger than 15 years old. The
study demonstrated that 80%of the childrenwhowere anergic
to the TST were also anergic to the candida test. Complement
levels were raised in all groups (with and without active TB),
and IgA and IgG titers were higher in children with TB. These
results suggest a possible defect in the group’s nonspeciﬁc
cellular immune response.23
Table 2 – Characterization of the studies that investigated gene
cytokines involved in the immune response to TB in indigenou
Authors Year of
publication
Language Ethnic
groups/location
Trejaut et al. 2004 English Ami, Tsou,
Atayal and
Tao/Taiwan
Larcombe et al. 2005 English Cree/Canada
Torkildsen et al. 2005 English Sami/Norway
Amirzargar et al. 2006 English Yazd/Iran
Larcombe et al. 2008 English Dené and
Cree/Canada
Zembrzuski et al. 2010 English Xavante/Brazil13;17(3):363–368
Araujo et al. have evaluated the levels of the C3 and C4
complement components in a case–control study, comparing
members of the adultWarao population to a Creole population
in the region. The authors have observed lower complement
levels in the indigenous people and concluded that the deﬁ-
ciencymay relate to defects in opsonization and phagocytosis,
thus explaining this population’s greater susceptibility to TB.25
Araujo et al. have investigated immunoglobulin concentra-
tions and cutaneous sensitivity test results (TST and candida
skin test) among Warao children ≤15 years old to evaluate the
diagnostic performance of these measurements. The authors
have observed that 80% of the children did not respond to the
TST or candida test,24 an estimate similar to the one reported
by González et al.23 In addition, the patients with active TB
who did not react to the TST exhibited elevated IgE concen-
trations, suggesting a predominantly Th2 immune response.24
Sanchez-Rodriguéz et al. have conducted a study in
Totonaca, Mexico to determine if the IgG concentrations
observed after Ag85 stimulation could be useful for TB diag-
nosis. Of the 55 indigenous TB carriers evaluated, a third
produced negative immunoblots. The authors have concluded
that the population’s genetic characteristics and nutritional
deﬁcits could be linked to the test’s poor performance.28
Despite a distinct immune response toTB in the indigenous
population, studies demonstrated that there are no differ-
ences regarding to severity and clinical forms of illness as
compared with the non-indigenous population.29–31 Only six
studies that analyzed polymorphisms in cytokine genes in
indigenouspeoplewere identiﬁed (Table 2).Most of these stud-
ies only compared genetic and/or genotype frequencies in
distinct populations and did not investigate the factors asso-
ciated with the immune response.
Larcombe et al. have analyzed the cytokine gene promoter
regions of Canadian aborigines and found that polymor-
phisms related to the Th2-type immune response were
common in this population.32 In another study, the same
research group had examined the frequency of these poly-
morphisms in an indigenous population with a high TB
prevalence. Despite the small sample size, the results indicate
that the populations, especially the Dené, may develop a less
efﬁcient Th1-type response, reinforcing their prior ﬁndings.33
tic polymorphisms associated with the expression of the
s populations.
Sample size Genes Age (y)
50 (Ami, Tsou,
and Atayal; each)
and 40 (Tao)
IL1A, IL1B, IL1R,
IL1RA, IL2, IL4, IL4RA,
IL6, IL10, IL12, IFNG,
TNFA, TGFB
Not speciﬁed
78 IL6, IL10, TNFA,
TGFB1, IFNG
18–60
200 IL10 Not speciﬁed
121 IFNG, TNFA, IL2, IL4,
IL6, IL10
Not speciﬁed
61 (Dené) and 42
(Cree)
TNFA, INFG, IL6 Mean 41 (Dené)
481 IL1B, IL12RB1,
IFNGR1, TNFR1, IFNG,
IL2, IL10, IL6, IL4, IL4R
0.3–91.7, mean
18.8
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Zembrzuski et al. have investigated the Xavante popula-
ion, which lives in Brazil’s central region and has a high
B prevalence. The authors have examined potential asso-
iations between polymorphisms in cytokine genes and TST
esponses. The study revealed that the absence of a TST
esponse (anergy) may be associated with a predominantly
h2 pattern, which may increase an individual’s susceptibility
o TB disease.22
Three other studies that analyzed native populations in
ran, Norway and Taiwan compared the frequencies of poly-
orphisms in cytokine genes between native groups and
ther populations (Caucasians, Afro-descendants andAsians).
he studies found that the presence of speciﬁc polymor-
hisms in these populations speciﬁc polymorphisms were
mportant predictors of disease susceptibility and clinical
anifestations of disease. The differences observed may
artly explain the disproportionate prevalence and risk of
rogression from infection to disease with some pathogens,
articularly TB, in indigenous populations.7,34,35
onclusion
lthough few scientiﬁc studies of indigenous populations’
mmune responses to TBhave beenpublished in the past three
ecades, the 13 studies analyzed here showed that Th2-type
esponses predominate in indigenous groups, indicating that
hese groups probably harbor an immunogenetic susceptibil-
ty to TB.
This review has shown that the immune response to TB in
ndigenous populations is different from the response in the
eneral population. Adequate knowledge of genetic polymor-
hisms and their role in the immune regulation of indigenous
opulations could clarify the immunogenetic mechanisms
nvolved in the response to TB. This information would be
seful for improve the diagnosis methods, identify new treat-
ents and prevent infection and progression to active disease
n these populations.
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